Related references
Note: Only part of the references are listed.Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States
Hyun-seok Kim et al.
JOURNAL OF HEPATOLOGY (2022)
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation
Shanshan Wu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients
Shun Kaneko et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
Honglian Gui et al.
FRONTIERS IN MEDICINE (2021)
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
Hwai- Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog
Sakura Kirino et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update
Ryoichi Ando et al.
HEPATOLOGY RESEARCH (2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan et al.
JOURNAL OF HEPATOLOGY (2020)
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
Shun Kaneko et al.
SCIENTIFIC REPORTS (2020)
Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
Terry Cheuk-Fung Yip et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2019)
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
Ken Liu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
Ji Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis
Haruhiko Takeda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir
Chien-Hung Chen et al.
ONCOTARGET (2017)
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection
Mahmoud Abu-Amara et al.
GUT (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Validation of Hepatitis B Virus-Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy
Kyu Sik Jung et al.
HEPATOLOGY (2015)
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Catherine de Martel et al.
HEPATOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2015)
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends et al.
GUT (2015)
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho et al.
GUT (2014)
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
Grace Lai-Hung Wong et al.
JOURNAL OF HEPATOLOGY (2014)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection
Osamu Yokosuka et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
